The Conductivity Change in the Course of Ion Exchange Chromatography: Effects on the Biological Activity and Isoforms of Human Recombinant Erythropoietin by Mardani, Rajab et al.
Archive of Advances in Biosciences2019:10(2)                                                                doi.org/10.22037/aab.v10i2.17423 
Archive of Advances in Biosciences is an open access article under the terms of the Creative Commons Attribution -NonCommercial 4.0 International License,  
35 
Original Article 
The Conductivity Change in the Course of Ion Exchange 
Chromatography: Effects on the Biological Activity and 













Department of Biochemistry, Taft Branch, Payam Noor University, Yazd, Iran 
2
Department of Nanobiotecnology, Faculty of New Science and Technology, Tehran University, Tehran, Iran 
3








 Revised: 2019-05-26 
Accepted: 2019-05-28 
Abstract 
Introduction: Recombinant human erythropoietin (rhEPO) has been produced 
in different conditions and cell lines. Identification, isolation, and purification 
of this protein from various sources have pivotal role in clinical applications. 
Hence, Clinical trials should be carried out for the identification of purity and 
aggregation of biological EPO.  Moreover, the purification of EPO cooperates 
with various recommended processes has been manifested, but the strategies 
schemes (i.e., liquid chromatography (HPLC) and ion exchange 
chromatography (IEX) are often used in combination. In the current study, the 
quality of purification, biological modifications and the stability of rhEPO 
using various chromatography methods including HPLC and IEX have been 
assessed.  
Materials and Methods: rhEPO was expressed in the Chinese hamster ovary 
(CHO) cells and purified by the general requirements for the quality control of 
biological products. For the assessment of the influence of IEX in the purity 
pattern of rhEPO, HPLC and biological analysis were performed for 3 samples.  
Results: Our results revealed that the combination of 4 strategies represent 
confident methods for evaluating the quality of this biological medicinal 
product; moreover, purity and biochemical applications will yield to a 
relatively pure protein preparation. The activity of EPO was presented by 
monomeric isoform and high acid sialic purification in final product. Moreover, 
the determination of the biochemical reactions rate and their relationship tests 
were obtained by change in electrical conductivity with pH being 31.5 and 5, 
respectively. 
Conclusion: Taken together, our results indicated that different purification 
process based on our results can increase the accuracy of rhEPO purification.  
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     Erythropoietin, also known as EPO, 
hematopoietic, or hemopoietinis is an 
endogenous hormone(34 kDa) with half-life 
of 5 hours, existing in blood with the 
concentration of around 10 mU/ml [1]. 
Interstitial fibroblasts of the kidney and per 
sinusoidal cells of the liver are major 
responsible cells for producing the EPO. 
EPO stimulates the erythrocyte precursors 
in the bone marrow. This protein helps the 
proliferation and differentiation of 
immature blood cells in bone marrow as 
erythropoiesis and oxygen delivery to the 
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tissues of body[2]. Given that, the EPO 
administration to check health of the 
individual and sports ethics can consider 
the use of EPO and its analogue drugs as 
blood doping cases. Moreover, several 
studies revealed that the EPO could be 
used as therapeutic agent in different 
pathological conditions such 
ashaematological and oncological 
disorders, HIV infection, and perioperative 
therapies. The EPO receptor is expressed 
on non-erythroid cells such as endothelial 
and brain cells.  The mutations of this 
protein is associated with emerging and 
developing different diseases. 
Erythropoietin could affect various 
biological processes such as hypertension, 
angiogenesis and cell survival [3]. 
Two forms of this protein, including 
epoitin alpha and beta are in market; 
nonetheless, both of endogenous and 
recombinant versions are available for 
utilization as therapeutic agents [4]. The 
improved life quality is the benefit of 
recombinant human EPO (rhEPO). It has 
been indicated that the detection of pure 
recombinant erythropoietin needs high 
cost processes [6, 11]. Erythropoietin is 
the most widely used recombinant drug 
across the world. Today, the rhEPO is used 
in the treatment of anemia, especially the 
treatment of anemia related to chronic 
kidney disease, dialysis and chemotherapy 
and anemia caused by HIV [4, 5]. Hence, 
developing new and effective purification 
platforms could contribute to more 
utilization of this form of protein in the 
clinical settings.  
In this regard, a variety of experiments are 
used for purification of rhEPO for the 
purpose of increasing the purity solution  
by control requirement concerns such as 
separation based on size and ionization of 
molecule [6].  
This well-designed and safe quality control 
results from stability testing, 
characterization and method validation by 
employing appropriate measures to ensure 
removing additional potential  
contaminants from products. Appropriate 
assessment does not have effect on 
biological potency. Changing some or all 
of these parameters such as a mixed mode 
ion-exchange chromatography matrix 
and/or utilization of the silica gel are ideal 
conditions and rapid purification 
strategies. Several columns using different 
details such as different types of sepharose 
and ultra-membrane filter as proper 
adsorption techniques can be performed 
for separation as a multiple-steps 
technique with high quality purification [7-
9]. The combination of chromatographics, 
including various modes of filtration, high 
performance liquid chromatography 
(HPLC), ion exchange chromatography 
(IEX) technique and multiple 
complementary analytical technique are 
important for safe purification of various 
molecules [4, 8]. These analytical 
methodologies used for quality control 
(QC) of erythropoietin are used for drug 
development processes like Mab [10-12]. 
Dobrila et al., used three different high-
performance liquid chromatographic 
(HPLC) techniques, i.e. affinity, ion 
exchange, and gel filtration 
chromatography without prior ammonium 
sulphate precipitation to purify polyclonal 
antibodies from bovine serum. The result 
showed that the rapid HPLC techniques 
were found to be very useful for the 
purification of polyclonal antibodies on a 
preparative scale means up to 25 mg of 
serum protein [13]. 
Sohraby et al., purified the recombinant 
factor VIII by production and purification 
of rabbit’s polyclonal anti-body against 
factor VIII. Different techniques such as 
ion x change, affinity chromatographies, 
and ammonium sulfate precipitation of 
IgG or caprilic acid methods have been 
applied. The antibody was separated from 
the blood, purified and used to identify 
factor VIII [14]. Herein, we assessed the 
extended purification, release testing, and 
stability testing of rhEPO using various 
modes of chromatography including 
HPLC, IEX and gel filtration. 
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2. Materials and Methods 
2.1 Cell culture 
     Chinese hamster ovary (CHO) were 
obtained from Pasture Institute, Iran. CHO 
cells expressed rhEPO were cultured in 
DMEM media containing 10% FBS (fetal 
bovin serum) for 48 h at 37°cwithout 
antibiotic. This media was substituted by 
DMEM media containing 5% FBS.  The 
cell culture supernatant was harvested; 
then, the bottle adherent cell was separated 
by trypsination (for 2 times) and added to 
the solution. The insulin for removing FBS 
and PBS for solution washing was added. 
Cell culture filtration was done by 0/2 µm 
filter sterile. 
This study was approved by the Pasteur 
Institute’s  ethics committee (Ethical code: 
IR.PII.REC.1395.011). 
 
2.2 Gel Filtration 
     Gel filtration is a way to achieve the 
highest purity unaffected by buffer 
conditions, with limited volume capacity 
and sample size. Gel filtration was 
performed by the 60 ml of harvest that was 
loaded onto 185 ml of G-25Sepharosepre-
equilibrated with sodium acetate (50 Mm) 
and tween 0/01 % buffer pH 5 at 3.7 
ml/min flow rate until final fluid had pH: 
5. Eluted result of gel filtration is well 
suited for use for other chromatographic 
techniques such as IEX. In this research, 
60 ml elute including recombinant EPO 
and components as contaminant with 3.7 
flow rate were described as sample. For 
this elution, sodium acetate at pH:5 and 
con:3-5 was used.  
 
2.3 Ion Exchange Chromatography 
(IEX) and Ultrafiltrarion 
     XK50/2 chromatography column was 
prepared by 70 ml Q-Sepharose fast flow 
media pre-equilibrated with above-
mentioned buffer at 20.1 mL/min flow 
rate. IEX is a technique which offers 
different solutions, either anion or cation 
exchangers. The pH of the performance 
can be modified to alter the charge 
characteristics of the sample components 
such as EPO. The column was equilibrated 
to the desired pH: 4 and 5. After passing 
the eluted fraction solution including EPO 
down the column, recombinant EPO was 
sequentially eluted with increasing 
concentrations of pH and concentration in 
the original buffer. Our experiment was 
based on modification of pH and electrical 
conductivity of different buffers. In this 
step, the first buffer (sodium acetate 50 
mM, tween 20 0/01%) with pH: 5 and con: 
3-5 was used as contamination and low 
sialic acid removing buffer, second buffer 
(sodium acetate 50 mM, tween 20 0/01%) 
with pH: 5, con: 3-5 (original buffer for 
eluting and EPO and sialicacid 
concentration increasing fraction) and 
third buffer was obtained with different 
electrical conductivity  including 1: 
Sodium acetate 50 mM, tween 20 0/03% , 
con 30 with pH: 5, 2: Sodium acetate 50 
mM, tween 20 0/01% , con 3-5 with pH: 4, 
3: Sodium acetate 50 mM, tween 20 
0/03% , and con 31.5 with pH: 5. 
Consequently, 75 ml of gel filtration 
elution was divided into 3 part solutions to 
be used for  3 columns separately. After 
any eluting, OD of every solution was 
measured. Fractions of these steps were 
analyzed by SDS-PAGE 12% for total 
protein and purity percentage. HPLC was 
used for eluting purposes. The 
ultrafiltration was concentrated by using a 
10 KDa filter Amicon-Ultra (Millipore) 
into 15 ml elution.  
 
2.4 HPLC Chromatography 
     The whole experiment was performed 
on HPLC instrumentation, consisting of 
2.95 mL/min flow rate to an XK 26/70 
column packed with 25.5 mL of high 
resolution gel filtration chromatography 
super grade × 200, prep grade media 
equilibrated with di sodium hydrogen 
phosphate buffer 70 mM, sodium 
hydrogen phosphate 2 H2O  30 mM, NaCl 
50 mM buffer  and tween 20 0/02% with 
con 15-17, pH: 7. HPLC samples were 
collected to test isoform and biological 
activity. The other techniques can be used 
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for the identification, assessment of purity 
and monomer, dimer and aggregation 
biological form of EPO using mouse 
injection. OD result manifested that the 
first pick belonged to aggregated form, 
second and third pick were dimer and 
monomer form of EPO respectively. 
 
3. Results  
Gel Filtration  
This technique is based on separation by 
molecular mass, but here, it acts as a 
reducer of the conductivity. Hence, it 
provides a new possibility for separation 
of EPO from contaminant protein (not for 
purification). The decrease of pH from 
mobile phase to pH:4 confirmed that some 
contaminations were removed and also 
erythropoietin was deglycosylated. It 
means, the optimized pH for this 
application is 4. The result of gel filtration 
is depicted in Figure 1. 
 
 
Figure 1.  Gel filtration elution. The optimized pH is 4. 
 
Ion Exchange Chromatography 
     In the anionic exchange 
chromatography of the basic form of 
erythropoietin, sialic acid was decreased 
and some other contaminants were 
increased. The mobile phase conductivity 
changing into 3 columns showed that the 
best purified fraction was eluted from 
anion exchange column, which was the 
sample with PH: 5 and 31.5 electrical 
conductivity and 27.7% purity (Table 1). 
 
Table 1. Total protein and purity of final elution IEX 
Sample Total protein  Purity (SDS -PAGE) 
Elution1 0.073 41.2% 
Elution2 0.066 27.7% 
Elution3 0.051 17% 
 
 
HPLC Data Analysis 
 
Elute of  IEX column was used for HPLC 
(Figure 2). Finally, the output included 
HPLC results which showed 3 biological 
EPO called aggregation, dimer and 
monomer (biological forms). These had 3 
picks among which the sharpest one 
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Figure 2. HPLC result with 3 picks including aggregation, dimer and monomer for EPO elution. The highest pick is 
for monomer form, with high acid sialic 
4. Discussion 
     In the current study, we analyzed 
various procedures, including gel 
filtration, ultrafiltration, ion exchange 
chromatography and HPLC for 
erythropoietin purification. In this 
condition, the addition of minipore 
membrane was concentrated for HPLC 
chromatography. The combination of 
multiple purification steps yielded to a 
relatively pure EPO preparation.HPLC 
chromatography separated monomers, 
with the pick of electrical conductivity of 
31.5, which was sharper than others. The 
obtained and increased biological forms 
with high acid sialic were in accordance 
with standard chart. Despite the wide use 
of chromatography for purification 
purposes, manufacturers of purification 
strategies are critical for researchers 
performing multiplex assays. This 
recombinant hormone in the roll of drug 
must undergo other methods such as 
ELISA, RIA and uHPLC for clinical 
applications in the world. Epoetin (known 
as human recombinant erythropoietin) was 
approved by the Food and Drug 
Administration (FDA) [15]. It has a wide 
range of actions such asstimulation of 
angiogenesis and promoting cell survival 
via activation of EPO receptors which 
resulted in anti-apoptotic effects on  
 
ischemic tissues. Given that, EPO caused a 
prompt decrease in plasma levels of renin 
and aldosterone [16]. Renal clearance 
studies suggested that EPO decreases renal 
proximal tubular reabsorption rate leading 
to activation of the tubuloglomerular 
feedback mechanism and a fall in 
glomerular filtration rate [17]. Thus, 
treatment with EPO may result in the 
suppression of endogenous EPO 
production through a decrease in intra-
renal oxygen consumption [6, 11]. The 
cDNA clones of physiologic EPO have 
been isolated from different host cells, 
such as ovarian cells of Chinese hamster 
(CHO) and kidney cells from hamster cub 
[4, 5, 18]. A wide range of applications of 
EPO led to researchers attempt to discover 
or develop new high-throughput 
expression model, isolation and 
purification approaches which are 
associated with low costs and also could 
be easily introduced to clinical 
settings[6]For EPO, similar to other 
biologics, certain regulations quality 
control is necessary. The purification of 
target molecules from contaminants may 
require high identity, purity, strength, 
potency and safety strategies, like gel 
filtration and high performance liquid 
chromatography (HPLC). It is necessary to 
look at the possible detection of the 
contaminants and their deletion in the cell 
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extract and to add one or more steps to 
purification process [5, 7, 9]. 
Nebija et al. assessed the characterization 
of the quality attributes including 
structural integrity, purity and stability of 
recombinant monoclonal antibody. The 
suitability of one-dimensional SDS-PAGE, 
under reducing and non-reducing 
conditions, and two-dimensional gel 
electrophoresis gel electrophoresis were 
Epoetin (known as human recombinant 
erythropoietin) was approved by the Food 
and Drug Administration (FDA) [15]. It 
has a wide range of actions such 
asstimulation of angiogenesis and 
promoting cell survival via activation of 
EPO receptors which resulted in anti-
apoptotic effects on ischemic tissues. 
Given that, EPO caused a prompt decrease 
in plasma levels of renin and aldosterone 
[16]. Renal clearance studies suggested 
that EPO decreases renal proximal tubular 
reabsorption rate leading to activation of 
the tubuloglomerular feedback mechanism 
and a fall in glomerular filtration rate [17]. 
Thus, treatment with EPO may result in 
the suppression of endogenous EPO 
production through a decrease in intra-
renal oxygen consumption [6, 11]. The 
cDNA clones of physiologic EPO have 
been isolated from different host cells, 
such as ovarian cells of Chinese hamster 
(CHO) and kidney cells from hamster cub 
[4, 5, 18]. A wide range of applications of 
EPO led to researchers attempt to discover 
or develop new high-throughput 
expression model, isolation and 
purification approaches which are 
associated with low costs and also could 
be easily introduced to clinical settings[6] 
For EPO, similar to other biologics, certain 
regulations quality control is necessary.  
The purification of target molecules from 
contaminants may require high identity, 
purity, strength, potency and safety 
strategies, like gel filtration and high 
performance liquid chromatography 
(HPLC). It is necessary to look at the 
possible detection of the contaminants and 
their deletion in the cell extract and to add 
one or more steps to purification process 
[5, 7, 9]. 
Nebija et al. assessed the characterization 
of the quality attributes including 
structural integrity, purity and stability of 
recombinant monoclonal antibody. The 
suitability of one-dimensional SDS-PAGE, 
under reducing and non-reducing 
conditions, and two-dimensional gel 
electrophoresis gel electrophoresis were 
valuated. They were analyzed for the 
recombinant monoclonal antibody, and 
trastuzumab. Results showed that it can 
bring about small pI  difference between 
the normal and the recombinant form of 
the antibody[19]. 
Eivazi and colleagues used the affinity 
chromatography based on sepharose beads 
conjugated with protein A and ion 
exchange chromatography column for 
purification of mouse IgG2b. In the last 
protocol, direct ELISA was used to 
determine the titer of HRP conjugated 
rabbit IgG. This study documented that 
ion-exchange chromatography and affinity 
chromatography could be appropriate 
techniques for the purification of the 
antibody [11]. 
Bergmann-Leitner focused on two 
precipitation methods and two affinity 
chromatography-based separation methods 
and compared them for purifying rabbit 
and human. Also, human IgG was purified 
through different methods. In this regard, 
the significant lower titers of purified Igs, 
were observed. Meanwhile, no changes in 
the binding  avidity (ED50 = 2.0 M for both 
sample) were observed[10]. 
Melkerson et al. purified the CMP-sialic 
acid lactosylceramide alpha 2,3-
sialyltransferase (SAT-1), 40,000-fold to 
apparent homogeneity from rat liver Golgi 
through affinity chromatography twice on 
CMP-hexanolamine and once on 
lactosylceramide aldehyde-Sepharose 4B. 
Identification of the protein was detected 
through Western blot and immune protocol  
[9]. 
In a study, Gebauer et al. applied the lipid-
enveloped viruses for the immunoglobulin 
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production by ion-exchange 
chromatography on Q-Sepharose Fast 
Flow (FF). The ionic strength of the 
starting buffer caused the elution of 
immunoglobulins, but did not affect 
immunoglobulin classes[8].  
Miyake and colleagues employed a seven-
step separation approach with a total EPO 
yield of 21%, which 
used size-exclusion,  ion-exchange, and 
multimodal hydroxyapatite 
chromatography [20]. 
Utilization of affinity chromatography is 
another approach which could be used for 
purification of EPO. A very recent work, 
conducted by Kish et al. indicated that 
affinity chromatography which used cyclic 
peptide ligands, is a high efficacy 
purification approach for EPO [21].  
 
5. Conclusion  
     In conclusion, this study is associated 
with some limitations. It seems that 
comparison between various platforms for 
purification of EPO are needed for 
obtaining more comprehensive results. 
Moreover, recent studies are carried out 
through new platforms such as MALDI-
MS, and affinity chromatography using 
cyclic peptide ligands for evaluating the 
purification of EPO [6]. Thus, the 
comparison of the used platforms with 
new techniques could be related to 
devolving new and low costs purification 
approaches. 
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